Huberman Lab cover image

Dr. Chris Palmer: Diet & Nutrition for Mental Health

Huberman Lab

Semagluetide and GLP-1 Related Compounds - What Are Your Thoughts?

2min Snip

00:00
Play full episode
There's a new class of drugs that I think initially were developed to treat diabetes but are now being evaluated for their efficacy to treat obesity. These are the semagluetide drugs that are involved in, they tap into these glucagon-related GLP-1 pathways and this is a story that we've talked about a little bit on the podcast before. The real answer is I am not at all an expert on these medications. They obviously adjust the way that glucose and insulin are managing energy both in the body and the brain and can produce weight loss. But a good logical shift in diet and exercise could achieve similar weight loss but a lot of people just won't do that.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode